Partner Content Partner Content Peripheral Interventions Market will achieve 8.7% CAGR up to... Peripheral Intervention Industry to hit $10.5bn by 2025
News Rezzayo antifungal okayed as Candida auris rings alarm bells Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
R&D Sponsored An inside guide to unlocking clinical research in the UK An inside guide to unlocking clinical research in the UK
